We use cookies on our site to track usage and preferences. Learn more

Healing and feeding the world

In the life sciences sector, companies are working on both medical and agricultural products and services.


The Park is currently home to 34 biomedical companies working on a wide range of products and technologies spanning disease prediction and prevention to diagnostics, treatment and patient monitoring. This number will increase significantly when the new 40,000 sq ft BioHub opens next year.

  • 12 companies are involved in the research and development of therapeutics. This includes small molecule drug discovery, biologics, immuno-therapies and generics across multiple disease areas
  • 7 companies specialise in medical products including non-invasive diagnostics and wearables
  • 14 companies are developing platform technologies or products and services for research scientists. These include suppliers of antibodies, informatics and data services, regulatory and technical consulting


In the agri-tech sector, the Park is home to companies working on crop protection products for professional farmers and growers.


The latest news, discoveries and innovations in life science

See all Life Sciences news


Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases

TWEET by @Bayer4CropsUK

Rodents can cause a range of issues on farms: ▪ Contaminating and devaluing grain stocks ▪ Damage to buildings and machinery ▪ Source of many diseases such as Leptospirosis Here's how to manage the challenge 👇 cropscience.bayer.co.uk/blog/articles/…


KTP Grant Expedites Development of Nuclera’s Desktop Gene Printer

TWEET by @SupplantCompany

A new projection from charity @DiabetesUK says that 1 in 10 people in the UK will be diagnosed with #diabetes by 2030: hubs.ly/H0ZsRT00 #risingobesity #obesity


Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic


Three UK biotechnology companies will combine research expertise to develop fully synthetic animal-free scaffolds to overcome barriers in sustainable and scalable organoid culture, in a project funded by Innovate UK.


Cambridge Consultants announces its collaboration with MedTech Innovator, a world-leading non-profit start-up accelerator


Device for treating gait deficit caused by multiple sclerosis receives FDA marketing authorization


Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test


Owlstone Medical Announces Key Study Results on use of Breath Biopsy for Improved Detection of Liver Disease including NASH and NAFLD

Contact us

Thank you for your enquiry!
We'll be in touch soon.

We couldn't send your message.
Please review the fields then try again